
Integer Holdings Corporation Long-Term Debt | ITGR
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Integer Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.19 B | 980 M | 960 M | 907 M | 813 M | 694 M | 777 M | 888 M | 1.58 B | 1.69 B | 175 M | 198 M | - | 225 M | 236 M | 221 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.69 B | 175 M | 768 M |
Quarterly Long-Term Debt Integer Holdings Corporation
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67.4 M | 67.1 M | 69.3 M | 81.9 M | 82.7 M | 83.9 M | 85.7 M | 77.7 M | 69.1 M | 71.9 M | 74.3 M | 72.1 M | 57.3 M | 60 M | 62 M | 64 M | 62 M | 64.4 M | 64.3 M | 59.8 M | 41.4 M | 43.1 M | 45.2 M | 37.9 M | 39 M | 40.6 M | 42.5 M | 37.1 M | 38.7 M | 39.8 M | 33.8 M | 888 M | 954 M | 1.54 B | 1.56 B | 1.61 B | 1.63 B | 1.67 B | 1.7 B | 1.73 B | 1.75 B | 1.76 B | 1.76 B | 1.71 B | 180 M | 182 M | 185 M | 187 M | 190 M | 192 M | 195 M | 198 M | 210 M | 237 M | 233 M | 225 M | 230 M | 233 M | 239 M | 236 M | 198 M | 206 M | 236 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.76 B | 33.8 M | 414 M |
Long-Term Debt of other stocks in the Medical devices industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
2.16 M | - | - | $ 162 M | ||
|
Avinger
AVGR
|
1.1 M | - | -20.74 % | $ 369 K | ||
|
Zynex
ZYXI
|
789 K | - | - | $ 21.1 M | ||
|
Invacare Corporation
IVC
|
354 M | - | - | $ 24.7 M | ||
|
Neovasc
NVCN
|
273 K | - | - | $ 111 M | ||
|
CONMED Corporation
CNMD
|
834 M | $ 46.69 | 0.39 % | $ 1.45 B | ||
|
ShockWave Medical
SWAV
|
732 M | - | - | $ 12.3 B | ||
|
Nevro Corp.
NVRO
|
188 M | - | - | $ 217 M | ||
|
Allied Healthcare Products
AHPI
|
2.93 K | - | 3.58 % | $ 2.21 M | ||
|
Axonics Modulation Technologies
AXNX
|
25.8 M | - | - | $ 3.31 B | ||
|
Cardiovascular Systems
CSII
|
1.33 M | - | 0.15 % | $ 844 M | ||
|
ThermoGenesis Holdings
THMO
|
131 K | - | -25.84 % | $ 171 K | ||
|
Talis Biomedical Corporation
TLIS
|
16.8 M | - | 3.55 % | $ 7.96 M | ||
|
Abiomed
ABMD
|
6.62 M | - | - | $ 17.2 B | ||
|
Titan Medical
TMDI
|
981 K | - | -26.32 % | $ 19.6 M | ||
|
SmileDirectClub
SDC
|
849 M | - | -53.45 % | $ 9.71 M | ||
|
Cutera
CUTR
|
1.06 M | - | -10.19 % | $ 1.99 M | ||
|
Sientra
SIEN
|
55.4 M | - | -16.59 % | $ 10.3 M | ||
|
Acutus Medical
AFIB
|
25.6 M | - | -26.83 % | $ 2.62 M | ||
|
Viveve Medical
VIVE
|
425 K | - | -15.35 % | $ 1.71 M | ||
|
MiMedx Group
MDXG
|
16.5 M | $ 3.06 | -1.77 % | $ 452 M | ||
|
Venus Concept
VERO
|
31.4 M | - | - | $ 726 K | ||
|
Eargo
EAR
|
11.9 M | - | - | $ 10.2 M | ||
|
Surgalign Holdings
SRGA
|
10.6 M | - | -32.98 % | $ 1.68 M | ||
|
BIOLASE
BIOL
|
11.8 M | - | -13.19 % | $ 166 K | ||
|
SeaSpine Holdings Corporation
SPNE
|
5.87 M | - | 0.28 % | $ 270 M | ||
|
Inari Medical
NARI
|
30.4 M | - | - | $ 4.23 B | ||
|
Apollo Endosurgery
APEN
|
34 M | - | - | $ 475 M | ||
|
NuVasive
NUVA
|
872 K | - | - | $ 2.07 B | ||
|
Conformis
CFMS
|
20.6 M | - | - | $ 16.4 M | ||
|
ViewRay
VRAY
|
73.3 M | - | 1.54 % | $ 468 M | ||
|
Medigus Ltd.
MDGS
|
468 K | - | 10.28 % | $ 55.5 M | ||
|
Abbott Laboratories
ABT
|
9.9 B | $ 103.08 | -0.98 % | $ 179 B | ||
|
Align Technology
ALGN
|
82.5 M | $ 154.77 | -3.07 % | $ 11.2 B | ||
|
Vapotherm
VAPO
|
2.92 M | - | 6.72 % | $ 34 M | ||
|
Silk Road Medical, Inc
SILK
|
75.6 M | - | - | $ 1.07 B | ||
|
Alphatec Holdings
ATEC
|
501 M | $ 6.66 | -3.48 % | $ 999 M | ||
|
Boston Scientific Corporation
BSX
|
11.1 B | $ 41.95 | -2.43 % | $ 62.1 B | ||
|
Natus Medical Incorporated
NTUS
|
6.57 M | - | 1.94 % | $ 1.05 B | ||
|
Nemaura Medical
NMRD
|
3.09 M | - | -17.8 % | $ 2.74 M | ||
|
Butterfly Network
BFLY
|
17.7 M | $ 5.39 | -8.28 % | $ 1.33 B | ||
|
Bio-Rad Laboratories
BIO
|
1.2 B | $ 358.56 | -2.43 % | $ 9.78 B | ||
|
Edwards Lifesciences Corporation
EW
|
598 M | $ 101.86 | -1.94 % | $ 59.6 B | ||
|
Aethlon Medical
AEMD
|
337 K | $ 5.49 | 13.33 % | $ 3.7 M | ||
|
Apyx Medical Corporation
APYX
|
34.8 M | $ 2.39 | 2.06 % | $ 98.2 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
71.3 M | - | - | $ 1.77 B | ||
|
Cognyte Software Ltd.
CGNT
|
1.13 M | $ 7.27 | -6.56 % | $ 530 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
430 K | - | -5.86 % | $ 30.6 M | ||
|
Medtronic PLC
MDT
|
26.2 B | $ 99.64 | -1.0 % | $ 128 B |